Cite

HARVARD Citation

    Delitto, D. et al. (n.d.). 231 A novel discovery pipeline identifies melanoma-specific antibodies in patients responding to immune checkpoint inhibitors. Journal for immunotherapy of cancer. p. A138. [Online]. 
  
Back to record